First Time Loading...

Health Catalyst Inc
NASDAQ:HCAT

Watchlist Manager
Health Catalyst Inc Logo
Health Catalyst Inc
NASDAQ:HCAT
Watchlist
Price: 5.58 USD -2.02% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. [ Read More ]

The intrinsic value of one HCAT stock under the Base Case scenario is 10.38 USD. Compared to the current market price of 5.58 USD, Health Catalyst Inc is Undervalued by 46%.

Key Points:
HCAT Intrinsic Value
Base Case
10.38 USD
Undervaluation 46%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Health Catalyst Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling HCAT stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Health Catalyst Inc

Provide an overview of the primary business activities
of Health Catalyst Inc.

What unique competitive advantages
does Health Catalyst Inc hold over its rivals?

What risks and challenges
does Health Catalyst Inc face in the near future?

Has there been any significant insider trading activity
in Health Catalyst Inc recently?

Summarize the latest earnings call
of Health Catalyst Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Health Catalyst Inc.

Provide P/S
for Health Catalyst Inc.

Provide P/E
for Health Catalyst Inc.

Provide P/OCF
for Health Catalyst Inc.

Provide P/FCFE
for Health Catalyst Inc.

Provide P/B
for Health Catalyst Inc.

Provide EV/S
for Health Catalyst Inc.

Provide EV/GP
for Health Catalyst Inc.

Provide EV/EBITDA
for Health Catalyst Inc.

Provide EV/EBIT
for Health Catalyst Inc.

Provide EV/OCF
for Health Catalyst Inc.

Provide EV/FCFF
for Health Catalyst Inc.

Provide EV/IC
for Health Catalyst Inc.

Show me price targets
for Health Catalyst Inc made by professional analysts.

What are the Revenue projections
for Health Catalyst Inc?

How accurate were the past Revenue estimates
for Health Catalyst Inc?

What are the Net Income projections
for Health Catalyst Inc?

How accurate were the past Net Income estimates
for Health Catalyst Inc?

What are the EPS projections
for Health Catalyst Inc?

How accurate were the past EPS estimates
for Health Catalyst Inc?

What are the EBIT projections
for Health Catalyst Inc?

How accurate were the past EBIT estimates
for Health Catalyst Inc?

Compare the revenue forecasts
for Health Catalyst Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Health Catalyst Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Health Catalyst Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Health Catalyst Inc compared to its peers.

Compare the P/E ratios
of Health Catalyst Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Health Catalyst Inc with its peers.

Analyze the financial leverage
of Health Catalyst Inc compared to its main competitors.

Show all profitability ratios
for Health Catalyst Inc.

Provide ROE
for Health Catalyst Inc.

Provide ROA
for Health Catalyst Inc.

Provide ROIC
for Health Catalyst Inc.

Provide ROCE
for Health Catalyst Inc.

Provide Gross Margin
for Health Catalyst Inc.

Provide Operating Margin
for Health Catalyst Inc.

Provide Net Margin
for Health Catalyst Inc.

Provide FCF Margin
for Health Catalyst Inc.

Show all solvency ratios
for Health Catalyst Inc.

Provide D/E Ratio
for Health Catalyst Inc.

Provide D/A Ratio
for Health Catalyst Inc.

Provide Interest Coverage Ratio
for Health Catalyst Inc.

Provide Altman Z-Score Ratio
for Health Catalyst Inc.

Provide Quick Ratio
for Health Catalyst Inc.

Provide Current Ratio
for Health Catalyst Inc.

Provide Cash Ratio
for Health Catalyst Inc.

What is the historical Revenue growth
over the last 5 years for Health Catalyst Inc?

What is the historical Net Income growth
over the last 5 years for Health Catalyst Inc?

What is the current Free Cash Flow
of Health Catalyst Inc?

Financials

Balance Sheet Decomposition
Health Catalyst Inc

Current Assets 393.4m
Cash & Short-Term Investments 317.7m
Receivables 60.3m
Other Current Assets 15.4m
Non-Current Assets 308.4m
PP&E 39.6m
Intangibles 264m
Other Non-Current Assets 4.7m
Current Liabilities 89m
Accounts Payable 6.6m
Accrued Liabilities 26.6m
Other Current Liabilities 55.8m
Non-Current Liabilities 245.9m
Long-Term Debt 228m
Other Non-Current Liabilities 17.8m
Efficiency

Earnings Waterfall
Health Catalyst Inc

Revenue
295.9m USD
Cost of Revenue
-161.1m USD
Gross Profit
134.8m USD
Operating Expenses
-221.8m USD
Operating Income
-87m USD
Other Expenses
-31.2m USD
Net Income
-118.1m USD

Free Cash Flow Analysis
Health Catalyst Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

HCAT Profitability Score
Profitability Due Diligence

Health Catalyst Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

Health Catalyst Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

HCAT Solvency Score
Solvency Due Diligence

Health Catalyst Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
42/100
Solvency
Score

Health Catalyst Inc's solvency score is 42/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HCAT Price Targets Summary
Health Catalyst Inc

Wall Street analysts forecast HCAT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HCAT is 12.17 USD with a low forecast of 8.08 USD and a high forecast of 16.8 USD.

Lowest
Price Target
8.08 USD
45% Upside
Average
Price Target
12.17 USD
118% Upside
Highest
Price Target
16.8 USD
201% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

HCAT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

HCAT Price
Health Catalyst Inc

1M 1M
-31%
6M 6M
-28%
1Y 1Y
-56%
3Y 3Y
-89%
5Y 5Y
-86%
10Y 10Y
-86%
Annual Price Range
5.58
52w Low
5.53
52w High
14.32
Price Metrics
Average Annual Return -16.91%
Standard Deviation of Annual Returns 41.54%
Max Drawdown -91%
Shares Statistics
Market Capitalization 325.3m USD
Shares Outstanding 58 563 000
Percentage of Shares Shorted 2.95%

HCAT Return Decomposition
Main factors of price return

What is price return decomposition?

HCAT News

Other Videos

Company Profile

Health Catalyst Inc Logo
Health Catalyst Inc

Country

United States of America

Industry

Health Care

Market Cap

325.3m USD

Dividend Yield

0%

Description

Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm operates in two segments: technology and professional services. The technology segment includes its data platform, analytics applications and support services. Its solution consists of a cloud-based data platform, analytics software and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data from its software systems, which enables a range of analytics. Its software analytics application is built on top of its data platform to provide foundational or domain-specific insights that improve customers clinical, financial and operational performance. Its support services consist of both analytics experts and domain experts.

Contact

UTAH
South Jordan
10897 South River Front Parkway, #300
+18017086800.0
https://www.healthcatalyst.com/

IPO

2019-07-25

Employees

-

Officers

CEO & Director
Mr. Daniel D. Burton
Senior Advisor
Mr. Bryan Truman Hunt
Chief Commercial Officer
Mr. Kevin Freeman
CFO & Chief Accounting Officer
Mr. Jason Alger
Chief Operating Officer
Mr. Daniel LeSueur
Chief Technology Officer
Mr. Dave Ross
Show More
Senior Vice President of Investor Relations and Financial Planning & Analysis
Mr. Adam Brown
General Counsel & Secretary of the Board
Mr. Benjamin Landry
Chief Marketing & Communications Officer
Ms. Tarah Neujahr Bryan
Show Less

See Also

Discover More
What is the Intrinsic Value of one HCAT stock?

The intrinsic value of one HCAT stock under the Base Case scenario is 10.38 USD.

Is HCAT stock undervalued or overvalued?

Compared to the current market price of 5.58 USD, Health Catalyst Inc is Undervalued by 46%.